medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2002, Number 4

<< Back Next >>

Ann Hepatol 2002; 1 (4)

Extrahepatic manifestations of viral hepatitis

Amarapurkar DN, Amarapurkar AD

Language: English
References: 40
Page: 192-195
PDF size: 41.26 Kb.


Text Extraction

Viral hepatitis has been shown to be associated with various extrahepatic manifestations. These can be seen in both acute and chronic liver disease, may precede or follow overt liver disease. Aims and objects: To study the prevalence of extrahepatic manifestations of viral hepatitis and follow the course of the disease in response to antiviral therapy whenever indicated. Methods: Prospectively 448 patients of viral hepatitis were evaluated for extrahepatic manifestations and patients of glomerulonephritis (GN), polyarteritis nodosa (PAN) and cryoglobulinemia were tested for viral markers. All patients were investigated for liver and kidney function tests, hematological workup and viral markers such as HBsAg, HBeAg, Anti HBeAg, HCV RNA, IgM anti HAV and IgM anti HEV. Serum electrophoresis and kidney biopsies were done whenever indicated. In 10 cases of hepatitis B glomerulonephritis immunohistochemistry was done on kidney biopsies for demonstration of hepatitis B surface and core antigen. Results: Of total 448 cases 181 (40.4%) had hepatitis B infection, 142 (31.6%) had hepatitis C infection, 86 (19.1%) hepatitis E and 39 (8.7%) had hepatitis A infection. Extrahepatic manifestations were seen in 29 (6.4%) cases and these were cases of GN, PAN, cryoglobulinemia, thrombocytopenia, agranulocytosis, aplastic anemia and pancreatitis. Patients with hepatitis A with extrahepatic manifestations showed complete recovery in both hepatitis and extrahepatic manifestations. Six patients with PAN were treated with interferon of which 4 showed excellent response. Three patients of hepatitis B and hepatitis C related GN were given interferon and 4/6 responded well to treatment. Conclusion: Prevalence of extrahepatic manifestations with viral hepatitis was found to be 6.4%. These manifestations recover completely with recovery from viral hepatitis.


REFERENCES

  1. Seeff LB. Diagnosis, therapy and prognosis of viral hepatitis. In: Zakim D, Boyer TK, Eds. Hepatology: A textbook of liver disease, 2nd ed. Philadelphia; WB Saunders co, 1990; 981-984.

  2. Koff RS. Immunologically mediated extrahepatic manifestations of viral hepatitis. In: Krawitt EL, Wiesner RH Eds. Autoimmune liver diseases. New York: Raven press, 1991; 233-245.

  3. Koff RS. Viral hepatitis. In: Schiff L, Schiff ER. Ed. Diseases of the liver, 7th ed. Philadelphia JB Lippincott co. 1993; 535-545.

  4. Eigenbrodt E, Wase AJ. Renal involvement in hepatic disease, rheumatoid arthritis, Sjogren’s syndrome and mixed connective tissue disease. pp 522-547. In renal pathology with clinical & functional correlation, Tisher CC, Brenner BM, 1989, volu I, JB Lippincott company, Philadelphia.

  5. Czaja AJ, Carpenter HA, Santrach PJ, et al. Immunologic features and HLA association in chronic viral hepatitis. Gastroenterol 1995; 108: 157-164.

  6. Willson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997; 92: 4-17.

  7. Nagy J, Bajtai G, Brasch H, Sule T, Ambrus M, Deak GY, Hamori A. HBsAg in renal disease. Lancet 1978; 2: 315-316.

  8. Bajtai G, Ambrus M, Paal M, Nagy J, Deak GY. Hepatitis B antigenemia associated with progressive cirrhosis and membranous glomerulonephritis. Lancet 1975; 2: 102-103.

  9. Safadi R, Almog Y, Dranitzki- Elhalel M, Rosenmann E, Tur-Kaspa R. Glomerulonephritis associated with acute hepatitis B. Am J Gastroenterol 1996; 91: 138-139.

  10. Levy M, Kleinknecht C. Membraneous glomerulonephritis and hepatitis B virus infection. Nephron 1980; 26: 259-265.

  11. Wiggelinkhuizen J, Sinclair-Smith C, Stannard LM, Smuts H. Hepatitis B virus associated membraneous glomerulonephritis. Archives of Disease in childhood 1983; 58: 488-496.

  12. Southwest pediatric nephrology study group. Hepatitis B surface antigenemia in North American children with membraneous glomerulonephropathy. J Pediatr 1985; 106: 571-578.

  13. Brazosko WJ, Krawczynski K, Nazarewicz T, et al. Glomerulonephritis associated with hepatitis B surface antigen immune complexes in children. Lancet 1974; 2: 477-481.

  14. Lagrue G, Etievant MF, Sylvestre R, ET Hirbee G. Antigen Australie (Ag-HB) et glomerulonephrities. Nouv Presse Med 1974; 3: 1870-1872.

  15. Guardia J, Pedrira JD, Martinez-Vasquez JM, Vidal MT, Vilardell M, Caralps A, Ferrer E, et Bacardi R. Glomerulonephritis chroniques avec antigene Hb. Nouv Presse Med 1975; 4: 2923-2925.

  16. Nagy J, Bajtai G, Brasch H, Sule T, Ambrus M, Deak G, Hamori A. The role of hepatitis B surface antigen in the pathogenesis of glomerulonephritis. Clin Nephrol 1979; 12: 99-110.

  17. Amarapurkar DN, Amarapurkar AD, Kirpalani AL. Extrahepatic manifestations of viral hepatitis, hospital based study. J of Gastroenterol and Hepatol 2000; 15 (suppl): F30.

  18. Knecht GI, Chisari FV. Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen. Gastroenterology 1978; 75: 1152-1156.

  19. Lisker-Meiman M, Webb D, Di Bisceglie AM, et al. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha interferon. Ann Intern Med 1989; 111: 479-483.

  20. Conjeevaran HS, Hoofnagle JH, Austin HA, et al. Long tern outcome of hepatitis B virus related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995; 109: 540-546.

  21. Lin CY. Treatment of hepatitis B virus associated membranous nephropathy with recombinant alpha interferon. Kidney Int 1995; 47: 225-230.

  22. Gocke DJ, Hsu K, Morgan C, Bombardleri S, Lockshin M, Christian CL. Association between polyarteritis and Australia antigen. Lancet 1970; 2: 1149.

  23. Trepo CG, Thivolet J. Antigene Australien hepatite a virus et periarterite noveuse. Presse Med 1970; 78: 1575.

  24. Ziff M. Viruses and the connective tissue diseases. Ann Intern Med 1971; 75: 951.

  25. Duffy J, Lidsky MD, Sharp JT, et al. Polyarthritis, polyarteritis and hepatitis B. Medicine 1976; 55: 19-37.

  26. Sergent JS. Lockshin MD, Christian CL, Gocke DT. Vasculitis with hepatitis B antigenemia. Medicine 1976; 55: 1-18.

  27. Guillerin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 1995; 74: 238-253.

  28. Gorevic ED, Kassab SJ, Levo E, et al. Mixed cryoglobulinemia: clinical aspects and long term follow up of 40 patients. Am J Medicine 1980; 69: 287- 308.

  29. Jori GP, Buonanno G, D’Onofiro F, et al. Incidence and immunochemical features of serum cryoglobulin in chronic liver disease. Gut 1977; 18: 245-249.

  30. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver disease: Role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300.

  31. Mc Mahon BJ, Alberts SR, Wainwright RB, et al. Hepatitis B related sequelae: Prospective study in 1400 hepatitis B surface antigen positive Alaska native carriers. Arch Intern Med 1990; 150: 1051-1054.

  32. Foon KA, Mitsuyasu RT, Schroff RW, et al. Immunologic defects in young male patients with hepatitis associated aplastic anemia. Ann Int Medicine 1984; 100: 657-662.

  33. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J med 1997; 336: 1365-1372.

  34. Kojima S, Matsuyama K, Kodera Y, Okada J. Circulating activated suppressor T lymphocytes in hepatitis associated aplastic anemia. Ann J of Hematol 1989; 71: 147- 151.

  35. Brown KE, Tisdale J, Barrett J, Dunbar CE, Young NS. Hepatitis associated aplastic anemia. N Engl J Med 1997; 336: 1059-1064.

  36. Zeldis JB, Dienstag JL, Gale RP. Aplastic anemia and non-A, non-B hepatitis. Am J medicine 1983; 74: 64-68.

  37. Sherilock S. Fulminant hepatic failure in Sherilocks. Ed. Diseases of the liver and biliary system. London, Blackwell scientific publications. 1989: 116-128.

  38. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330: 1198-1210.

  39. Lopez Morante A, Rodriguez de hop C, Sam Miguel G, Pons Romero F. Acute pancreatitis in hepatitis A infection. Postgrad Med J 1986; 62: 407-408.

  40. Amarapurkar DN, Begani MM, Mirchandani K. Acute pancreatitis in hepatitis A infection. Tropical Gastroenterol 1997; 17: 30-31.




2020     |     www.medigraphic.com